US 12221627
Methods of enriching cell populations for cancer-specific T cells using in vitro stimulation of memory T cells
granted A61KA61K2239/50A61K40/11
Quick answer
US patent 12221627 (Methods of enriching cell populations for cancer-specific T cells using in vitro stimulation of memory T cells) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Feb 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Feb 11 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K2239/50, A61K40/11, A61K40/32, A61K40/4257